Altre lingue Murae Organisor Limited

Azioni

EARUM

INE060601023

Mercato chiuso - Bombay S.E. Altri mercati azionari 12:00:55 20/06/2024			Variaz. 5gg	Var. 1 gen.
1,46 ^INR	+1,39%		-1,35%	+26,96%

30/05	Murae Organisor Limited riporta i risultati degli utili per il quarto trimestre e l'intero anno terminato il 31 marzo 2024	CI
24/04	Murae Organisor Limited annuncia le nomine del Consiglio di amministrazione	CI

Altre lingue

Sblocca tutte le notizie: sii il primo a essere informato e reagisci prima dei mercati!

Registrazione 100% gratuita

Murae Organisor Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024	30/05
Murae Organisor Limited announced that it has received INR 247.499999 million in funding from IFL Enterprises Limited, Moneystar Tradelink Private Limited, Banke Tradelink Private Limited, Balmukund Tradelink Private Limited, Someshwara Tradelink Private Limited	29/05
Murae Organisor Limited Announces Board Appointments	24/04
Murae Organisor Limited Appoints Sangita Rajpurohit as Company Secretary and Compliance Officer	04/04
Earum Pharmaceuticals Limited Approves Board Resignations	15/03
Earum Pharmaceuticals' CFO Resigns	12/02
Earum Pharmaceuticals Limited Announces Resignation of Sunil Kumar Patel as Chief Financial Officer	10/02
Earum Pharmaceuticals Limited Approves Appointment of Vaghasiya Brijeshkumar Mathurbhai as Chief Financial Officer	09/02
Earum Pharmaceuticals Limited Announces Change in Corporate Office Address	09/02
Earum Pharmaceuticals Limited Announces Resignation of Sanjaykumar Nai as Non-Executive Director	19/01
Earum Pharmaceuticals Limited Announces Resignation of Vijaykumar Patel as Managing Director	19/01
Murae Organisor Names Managing Director	05/01
Earum Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	09/12
Earum Pharmaceuticals Limited Approves Board Changes	23/08/23
Earum Pharmaceuticals Names CFO	15/08/23
Earum Pharmaceuticals Limited Appoints Sunilkumar Patel as Chief Financial Officer	14/08/23
Earum Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	14/08/23
Earum Pharmaceuticals CFO Departs	10/08/23
Earum Pharmaceuticals Limited Announces Executive Changes	09/08/23
Earum Pharmaceuticals Limited Announces Change of Registered Office	09/08/23

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Murae Organisor Limited

Azioni

EARUM

INE060601023

Altre lingue

Filtri